Work in progressFolivue is still being built, so expect rough edges. Found a bug? Report it on the roadmap. Enjoying it? Buy me a coffee.Expect rough edges. Found a bug? Report it. Folivue is free. Want to help? Buy me a coffee.

Market snapshot

USEuropeAsiaLatin AmericaCurrenciesCryptoFutures

Dow Jones----S&P 500----Nasdaq----Russell----VIX----

Home›

Compare to

In the news

Keep browsing

You may be interested in

Help Roadmap & feedback Support Folivue Privacy Terms Disclaimer

ToolsStock return calculator Export Google Finance portfolios and watchlist to CSV

GuidesGoogle Finance classic view, rebuilt The new Google Finance, reviewed honestly The Google Finance redesign, explained A Google Finance alternative for classic users A Yahoo Finance alternative for people who miss the old one Google Finance without the AI Why did Google Finance change? Not because users asked The Google Finance portfolio: what changed, and how to keep tracking About Folivue

Folivue is not affiliated with, endorsed by or sponsored by Google LLC, Alphabet Inc., Yahoo, or any exchange or index provider. Market data comes from third parties, may be delayed or inaccurate, and is not investment advice; all other names and marks belong to their owners. Read the full disclaimer.

Market snapshot

Dow Jones0.26%53,417.16+140.16 S&P 5000.28%7,652.86-21.51 Nasdaq0.76%25,980.19-200.26 Russell0.76%2,995.08-22.79 VIX4.76%15.85+0.72

IT NOW ISE (ISUS.SA): Live Index Tracker & Chart | Folivue

Keep browsing

You may be interested in

TSLATesla, Inc.$348.95
3.83%
AMZNAmazon.com, Inc.$262.07
1.33%
AAPLApple Inc.$310.34
0.32%
AMDAdvanced Micro Devices, Inc.$456.75
3.49%
METAMeta Platforms, Inc.$559.02
1.66%
WTFCWintrust Financial Corporation$151.99
0.45%
PBProsperity Bancshares, Inc.$72.75
0.03%
VLYValley National Bancorp$14.10
0.42%

Home›ISUS.SA • SAO

IT NOW ISE

R$41.200.37%+0.15 Today

Closed: Aug 24, 11:34:33 PM UTC-3 · BRL · SAO · Disclaimer

$327.801.45%2.79%

ISUSTENTABILR$4,056.08ISEE.SA0.33%IT NOW ISE FUNDO DE ÍNDICE INVESTIMENTO SUSTENTÁVEL - RESPONSABILIDADE LIMITADAR$41.30ISUS11.SA0.78%S&P Japan 500 Shariah Index3,654.40SPSHJ0.23%iShares MSCI Emerging Markets I€29.86IUSE.SG2.05%UBS MSCI Switzerland H USD ETF USD dis$35.82SWUSAH.SW0.25%

In the news

Stock

US listed security

US headquartered

Previous closeR$41.05

Day rangeR$0.00 - 0.00

Year rangeR$0.00 - 22.49

Avg Volume0.00

GlobeNewswire•9 minutes ago

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion Stage 9887.HK5.65%

Stocktwits•12 minutes ago

NVDA Stock’s 7-Day Losing Streak Sets Up Make-Or-Break AI Earnings Test: Retail Expects Yet Another Beat